Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

Opening session and 2025 TAT Honorary Award

Welcome to the ESMO TAT Congress 2025 by the Scientific Co-Chairs

Date

03 Mar 2025

Session

Opening session and 2025 TAT Honorary Award

Presenters

Elena Garralda, Cristian Massacesi, Anastasios Stathis

Authors

E. Garralda1, C. Massacesi2, A. Stathis3

Author affiliations

  • 1 Early Drug Development Dept., Vall d'Hebron University Hospital, 8035 - Barcelona/ES
  • 2 Department Of Oncology Development, AstraZeneca - NY, 20878 - New York/US
  • 3 Medical Oncology Department, EOC - Ospedale Regionale Bellinzona e Valli - Istituto Oncologico della Svizzera Italiana (IOSI), 6500 - Bellinzona/CH

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.